Can Mounjaro Affect Your Heart? (October 2026)

01 · The core answer

Can Mounjaro affect your heart? The short answer

Yes, it can, and that is exactly why the heart question belongs in your consultation. Mounjaro is a powerful prescription medicine that acts on gut-hormone receptors, slows how quickly the stomach empties and changes how the body responds to insulin¹. A fast pulse is listed as a common side effect (up to 1 in 10 people) in the UK patient leaflet¹³.

If you already have a heart condition, have had a heart event, take heart or blood pressure medicines, or are simply worried, you need a clinician to look at your whole picture before you inject. Mounjaro is a prescription-only medicine supplied only after an online consultation reviewed by a GPhC-registered prescriber, and that consultation is where heart history is weighed up properly.

02 · What to decide

Is this relevant to you, and what should you do next?

It is relevant to you if you fall into any group in the table. Most people with no heart history will simply need to know which symptoms to report. People with an existing condition need a more careful conversation with a clinician.

Our next step for you depends on where you sit. If you have heart concerns, speak to your own doctor first and bring the leaflet. If you are well and ready to see whether you are suitable, the Mounjaro pen and free consultation is reviewed by a GPhC-registered prescriber before anything is dispensed. For the wider picture on weight management support, see our weight loss clinic.

Related reading covers heart rate changes, circulation questions and the broader question of whether it is good for your heart.

03 · What this page covers

Where to check heart effects

The Summary of Product Characteristics is the document written for prescribers and sets out the licensed use, warnings and listed undesirable effects¹. The Patient Information Leaflet in every pen box is the plain-English version and tells you which symptoms should prompt you to contact a professional¹³. The BNF entry for tirzepatide is the third reference prescribers use for dosing and safety¹¹.

If you notice something new, tell your prescriber; for chest pain, get medical help straight away. The right response is to tell a clinician and let them judge.

This page is information, not a substitute for medical advice, and individual results vary.

Mounjaro is licensed for weight management in adults and for type 2 diabetes¹. It is used alongside a reduced-calorie diet and increased physical activity.

04 · How it works

How Mounjaro works and why that matters for the heart

Mounjaro works by activating two natural gut-hormone receptors at once, and that is the starting point for understanding any body-wide effect. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹

Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. This dual action is what distinguishes Mounjaro from single-action medicines such as semaglutide, the active ingredient in Wegovy and Ozempic.

If you cannot keep fluids down, contact your clinical team — dehydration needs medical help straight away.

The medicine is given as a once-weekly injection through a pre-filled multi-dose pen in six strengths, from 2.5mg up to 15mg, and the dose is stepped up gradually under prescriber supervision¹. Gradual titration exists so the body can adjust, which is why new symptoms around a dose increase are worth noting and mentioning at your monthly review. If something changes the week after you move up a strength, say so, because that timing is useful information for the clinician.

For a deeper look at the class as a whole, see our guide on how this medicine class relates to the heart.

05 · Heart rate and palpitations

Heart rate, palpitations and what to do about them

If your heart feels like it is racing, pounding or fluttering after starting Mounjaro, get medical help straight away.

It helps to describe the symptom accurately when you get in touch. Note when it happens, such as after the injection, after meals, on standing or at night. Note how long it lasts and whether it comes with dizziness, breathlessness, chest tightness or fainting. Get medical help straight away for chest tightness, fainting or difficulty breathing. Mention what you have eaten and drunk, whether you have been sick, and whether you have had caffeine or alcohol. A short written note is more useful than a vague recollection at a review.

Some symptoms should not wait. Chest pain, severe breathlessness, fainting, a heartbeat that is irregular and will not settle, or symptoms that frighten you need medical help straight away. Seek emergency help through the usual NHS routes.

Our dedicated heart rate page goes further into this question.

Finally, if you have any symptom that you suspect is a side effect, you can report it yourself through the MHRA Yellow Card scheme¹⁹. These reports help regulators watch the safety of medicines across the whole population. A report is a signal for investigation, not proof that the medicine caused the symptom, and it never replaces speaking to a clinician about your own situation.

New symptoms always deserve a conversation with the prescriber¹¹³.

06 · Existing heart conditions

Is Mounjaro safe for heart patients?

Whether Mounjaro is suitable if you have heart disease depends on your individual circumstances and is a prescriber's decision. It depends on your condition, how stable it is, your other medicines and your overall health. That judgement belongs to a clinician who has your records or has taken your history carefully.

What you can do is prepare. Before a consultation, write down your diagnoses, any heart procedures or events, and every medicine you take, including ones for blood pressure, rhythm, cholesterol, clotting and diabetes. Include over-the-counter products and supplements. Be specific about dates and names if you can, and be candid about symptoms you currently have, even mild ones.

Our service is built around that review. The customer journey starts with a free online consultation, a short health questionnaire with no charge and no obligation. It is then reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. That structure exists so that a person with a heart history gets a human decision rather than an automatic one.

If you are under a cardiologist, tell them you are considering this medicine and ask what monitoring they would want. Specialist teams often know your baseline in a way no online form can capture. Do not stop or change any heart medicine yourself because you have started a weight management injection. The two are separate decisions and each needs professional guidance.

Tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin or sulfonylureas. For example, if you use insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. That is the kind of practical detail a prescriber will go through with you.

If your prescriber advises against Mounjaro for you, that is a safe outcome of the process, not a failure of it, and there are other routes to support, which your GP can discuss.

See also whether it is bad for your heart.

07 · Weight loss and heart risk

Weight loss results and what they do not tell you about the heart

Trial weight-loss results tell you how much weight people lost, not what happened to their hearts. It is worth keeping those apart, because the two are often blurred in headlines.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone². These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. Trial averages do not predict your own result, and they say nothing by themselves about cardiac outcomes.

For a more general discussion, see our page on whether it is good for your heart.

Who is the treatment aimed at? NICE recommends it on the NHS for adults with a BMI of at least 35 plus at least one weight-related condition⁴. Mounjaro is available on the NHS, but access is being phased in over several years. The primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions, and full rollout is expected to take years. Many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If your question is really about whether you should treat your weight for the sake of your heart, that is a conversation to have with your GP or cardiologist, who can weigh your individual risks. We can help you start the process in a safe, regulated way once you and your clinician agree it is appropriate.

08 · Comparing medicines

Ozempic or Mounjaro: how do they differ?

Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. The licensed weight-management options are Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg).

Mounjaro activates two receptors, GIP and GLP-1, whereas semaglutide, the ingredient in Wegovy and Ozempic, is a single-action medicine¹. That is a difference in mechanism, not a verdict on cardiac safety or benefit.

Licensing is another factor. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes. Wegovy has its own licence and dose ladder, and the Wegovy SmPC sets out its safety information¹⁸.

So how should you decide? Start with what you want the medicine to do. If the aim is weight management, the relevant comparison is between products licensed for it, looked at by a prescriber who knows your history. If you have a heart condition, ask your cardiologist or GP which they would favour and why, and ask them to point to the evidence they are relying on.

You can read about the alternative on our Wegovy pen page, and it is reasonable to compare both treatments in a consultation. Prescribers are well placed to discuss which option suits you, including the possibility that neither is right for you at this point.

A final caution: do not switch between medicines on your own because of something you read about the heart. Changing treatment affects dosing, side effects and monitoring, and it should be a clinical decision made with you.

09 · Serious side effects and stroke

Serious side effects, stroke and what to report

Serious side effects are listed in the patient leaflet and SmPC¹¹³.

Read the leaflet section on side effects, which separates those that need urgent help from those that do not¹³. Read the SmPC section on warnings if you want the prescriber-level wording¹. A symptom that is not on the leaflet list is not a listed side effect; tell your prescriber about any new or lasting symptom.

Some warning signs are worth knowing regardless of cause, because they need emergency care whatever has triggered them. Sudden weakness on one side of the body, drooping of the face, slurred speech, sudden severe headache, crushing chest pain or sudden collapse need emergency help: get medical help straight away or call 999.

For a persistent racing heartbeat or breathlessness that is new for you, get medical help straight away; tell your prescriber about any new swelling in the legs. Our aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support. Repeat orders re-check suitability, and there is no auto-shipping, so you are asked how you are before each new pen is sent.

Reporting matters too. The Yellow Card scheme lets patients and clinicians report suspected side effects¹⁹. A report does not prove cause, but it contributes to how regulators monitor medicines. You can make one yourself without going through a doctor. The MHRA also publishes guidance on safety matters, including counterfeit medicines⁷. That is relevant here because medicines bought from unregulated sellers offering to supply without a consultation or prescription carry unknown contents, and any heart effect from them is unpredictable.

Our supply is official LillyDirect supply, sourced directly from Eli Lilly's UK distribution, with genuine KwikPens. That does not remove the need for caution about symptoms, but it does remove the uncertainty about what is in the pen.

10 · Stopping and clearance

If you are worried, can you just stop?

If a symptom worries you, speak to a clinician before deciding whether to carry on. After a final dose it takes roughly 4–5 weeks to clear the system, and nothing needs doing while it clears.

That has two practical consequences for anyone with heart concerns. First, a symptom that began after an injection will not necessarily vanish the next day if you skip the following dose. Second, if you do experience something serious, tell the treating clinician exactly when your last injection was and which strength it was, because that timing shapes what they think is going on.

Stopping should always be planned with your prescriber. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued lost a further 5.5% on average. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time; if more than 4 days have passed, skip it and take the next one on your normal day — never take two doses within 3 days of each other.

If you are on a heart medicine and a prescriber decides to adjust it because of how you respond to Mounjaro, follow their instructions precisely. Never alter a heart or blood pressure tablet yourself.

How do you keep the process safe from the start? Use the structure that exists. Take the free online consultation seriously and answer fully. Make sure the prescriber knows your heart history. Attend monthly reviews. Keep the needles and sharps bin guidance that comes with every order to hand, and store pens in the fridge at 2–8°C; an in-use pen can be kept out of the fridge not above 30°C for up to 30 days after first use.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹